Sonic Healthcare expects its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) for the fiscal year 2024 to fall in the range of A$1.7 billion to A$1.8 billion.
The healthcare company also reported progress in its joint venture with Franklin.AI, stating it is nearing the completion of its first AI product.
Validation studies and field trials for this product are expected to start in early 2024.
Sonic Healthcare (ASX:SHL) is a global healthcare provider specializing in laboratory and radiology services.